Literature DB >> 16583638

Needle bleb revision of encapsulated filtering bleb with bevacizumab.

Malik Y Kahook1, Joel S Schuman, Robert J Noecker.   

Abstract

The utility of needle bleb revision with bevacizumab in a patient with a failing bleb following trabeculectomy is explored. The patient had previously failed needle bleb revision with mitomycin C. After needling and injection of 1 mg of bevacizumab, the bleb was noted to be more diffuse with a decrease in surface neovascularization. Bevacizumab may be an effective medication for rescuing failing filtering blebs that exhibit neovascularization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16583638

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  18 in total

1.  Application of intravitreal bevacizumab for circumscribed choroidal hemangioma.

Authors:  Min Sagong; Junyeop Lee; Woohyok Chang
Journal:  Korean J Ophthalmol       Date:  2009-06-09

Review 2.  [Inhibition of angiogenesis in the anterior chamber of the eye].

Authors:  F Bock; Y König; T Dietrich; P Zimmermann; M Baier; C Cursiefen
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

Review 3.  The control of conjunctival fibrosis as a paradigm for the prevention of ocular fibrosis-related blindness. "Fibrosis has many friends".

Authors:  Peng Tee Khaw; Yann Bouremel; Stephen Brocchini; Christin Henein
Journal:  Eye (Lond)       Date:  2020-06-25       Impact factor: 3.775

4.  Bevacizumab-loaded polyurethane subconjunctival implants: effects on experimental glaucoma filtration surgery.

Authors:  Jayter Silva Paula; Vanessa Raquel Coimbra Ribeiro; Fernando Chahud; Roberta Cannellini; Tassia Cristina Monteiro; Elionai Cassiana de Lima Gomes; Peter Sol Reinach; Maria de Lourdes Veronese Rodrigues; Armando Silva-Cunha
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-07       Impact factor: 2.671

Review 5.  Neovascular Glaucoma.

Authors:  Shane J Havens; Vikas Gulati
Journal:  Dev Ophthalmol       Date:  2015-10-26

Review 6.  [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery].

Authors:  J Lüke; M Lüke; S Grisanti
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

7.  ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol.

Authors:  Frank Bochmann; Claude Kaufmann; Christoph N Becht; Ivo Guber; Michael Kaiser; Lucas M Bachmann; Michael A Thiel
Journal:  BMC Ophthalmol       Date:  2011-01-17       Impact factor: 2.209

8.  Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma.

Authors:  Mohammad-Reza Sedghipour; Ali Mostafaei; Yousef Taghavi
Journal:  Clin Ophthalmol       Date:  2011-06-15

9.  Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: a case series.

Authors:  Carlos Gustavo Vasconcelos de Moraes; Antonio Carlos Facio; José Humberto Costa; Roberto Freire Santiago Malta
Journal:  J Ocul Biol Dis Infor       Date:  2009-03-31

Review 10.  Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery.

Authors:  Jin-Wei Cheng; Shi-Wei Cheng; Rui-Li Wei; Guo-Cai Lu
Journal:  Cochrane Database Syst Rev       Date:  2016-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.